Hamilton Thomas Edward

Average Profitability
20.65%
Insider Buys Quantity
5
Insider Buys Sum
$3.76M
Insider Sells Quantity
1
Insider Sells Sum
$1.47M

Insider Activity of Hamilton Thomas Edward

According to the SEC Form 4 filings, Hamilton Thomas Edward, being in a position of

  1. director at Larimar Therapeutics, Inc.,
    оver the last 12 months, has bought 57208 shares for $499,998, and sold 0 shares,
    over all time since 2021-06-30, has bought 431378 shares for $2M, and sold 0 shares.

The largest purchase of all time was on 2020-05-15 and amounted to 200000 shares of Annaly Capital Management, Inc. for $1.19M.

The largest sale of all time was on 2021-05-03 and amounted to 160000 shares of Annaly Capital Management, Inc. for $1.47M.

Biography of Hamilton Thomas Edward

No biography is available at this moment.

2024-02-16PurchaseLarimar Therapeutics, Inc.
LRMR
director
57,208
0.0891%
$8.74$499,998-39.36%
2022-09-16PurchaseLarimar Therapeutics, Inc.
LRMR
director
317,460
1.4059%
$3.15$999,999+21.88%
2021-06-30PurchaseLarimar Therapeutics, Inc.
LRMR
director
56,710
0.2763%
$8.75$496,213-2.39%
2021-05-03SaleAnnaly Capital Management, Inc.
NLY
director
160,000
0.0114%
$9.18$1.47M-3.85%
2020-05-15PurchaseAnnaly Capital Management, Inc.
NLY
director
200,000
0.0144%
$5.96$1.19M+38.94%
2019-05-17PurchaseAnnaly Capital Management, Inc.
NLY
director
60,000
0.0042%
$9.47$568,200-0.09%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.